Personal information

Activities

Collapse all

Works (12)

COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma

British Journal of Dermatology
2024-10-17 | Journal article
DOI: 10.1093/bjd/ljae258
Contributors: Mauro Esposito; Laura Yerly; Prachi Shukla; Victoria Hermes; Federica Sella; Zsolt Balazs; Evelyn Lattmann; Aizhan Tastanova; Patrick Turko; Ramon Lang et al.
Source: check_circle
Crossref

A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma

Nature Cancer
2024-08-29 | Journal article
DOI: 10.1038/s43018-024-00810-4
Contributors: Florentia Dimitriou; Phil F. Cheng; Annalisa Saltari; Katrin Schaper-Gerhardt; Ramon Staeger; Veronika Haunerdinger; Federica Sella; Aizhan Tastanova; Christian Urban; Susanne Dettwiler et al.
Source: check_circle
Crossref

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

EMBO Molecular Medicine
2024-08-20 | Journal article
DOI: 10.1038/s44321-024-00114-1
Contributors: Sarah Proteau; Imène Krossa; Chrystel Husser; Maxime Guéguinou; Federica Sella; Karine Bille; Marie Irondelle; Mélanie Dalmasso; Thibault Barouillet; Yann Cheli et al.
Source: check_circle
Crossref

LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

EMBO Molecular Medicine
2023-12-07 | Journal article
DOI: 10.15252/emmm.202317719
Contributors: Sarah Proteau; Imène Krossa; Chrystel Husser; Maxime Guéguinou; Federica Sella; Karine Bille; Marie Irondelle; Mélanie Dalmasso; Thibault Barouillet; Yann Cheli et al.
Source: check_circle
Crossref

Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

Cancer Research
2023-12-01 | Journal article
DOI: 10.1158/0008-5472.CAN-23-0485
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Data from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

2023-12-01 | Preprint
DOI: 10.1158/0008-5472.c.6960580
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Data from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

2023-12-01 | Preprint
DOI: 10.1158/0008-5472.c.6960580.v1
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Supplementary Data from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

2023-12-01 | Preprint
DOI: 10.1158/0008-5472.24710464.v1
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Supplementary Data from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

2023-12-01 | Preprint
DOI: 10.1158/0008-5472.24710464
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Table S3 from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

2023-12-01 | Preprint
DOI: 10.1158/0008-5472.24710461
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Table S3 from Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

2023-12-01 | Preprint
DOI: 10.1158/0008-5472.24710461.v1
Contributors: Lorenza P. Ferretti; Flurina Böhi; Deena M. Leslie Pedrioli; Phil F. Cheng; Elena Ferrari; Petra Baumgaertner; Abdiel Alvarado-Diaz; Federica Sella; Alessandra Cereghetti; Patrick Turko et al.
Source: check_circle
Crossref

Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma

Communications Biology
2023-08-10 | Journal article
DOI: 10.1038/s42003-023-05182-6
Contributors: Ulrike Lischetti; Aizhan Tastanova; Franziska Singer; Linda Grob; Matteo Carrara; Phil F. Cheng; Julia M. Martínez Gómez; Federica Sella; Veronika Haunerdinger; Christian Beisel et al.
Source: check_circle
Crossref
How many people are using ORCID?